SMTL ID : 7seg.1 (1 other biounit)

Crystal structure of the complex of CD16A bound by an anti-CD16A Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.16 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 6 residues within 4Å: Chain A: D.107, G.122, G.123 Chain B: G.65, Q.66, G.67 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:G.123 Water bridges: A:D.107

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)

NAG.2: 7 residues within 4Å: Chain C: H.47, N.48, V.66, D.67, S.69, G.70 Ligands: NAG.3 4 PLIP interactions: 4 interactions with chain C Hydrogen bonds: C:H.47, C:V.66, C:D.67, C:D.67 NAG.3: 3 residues within 4Å: Chain C: D.67, S.69 Ligands: NAG.2 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:D.67, C:D.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kakiuchi-Kiyota, S. et al., A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma. Leukemia (2022)

Release Date

2021-11-24

Peptides

anti-CD16a Fab light chain: A
anti-CD16A Fab heavy chain: B
Low affinity immunoglobulin gamma Fc region receptor III-A: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
C

anti-CD16a Fab light chain

anti-CD16A Fab heavy chain

Low affinity immunoglobulin gamma Fc region receptor III-A

Related Entries With Identical Sequence